Pretreatment Expression of 13 Molecular Markers as a Predictor of Tumor Responses After Neoadjuvant Chemoradiation in Rectal Cancer

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Annals of Surgery

• Publication date

  2014-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/SLA.0b013e31829b3916PMID 23787217
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Predictive Role of Sequential FDG-PET/CT in Response of Locally Advanced Rectal Cancer to Neoadjuvant Chemoradiation

  2012cited by this paper
• CD44 is a biomarker associated with human prostate cancer radiation sensitivity

  2011cited by this paper
• CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?

  2011cited by this paper
• Identification of a Biomarker Profile Associated With Resistance to Neoadjuvant Chemoradiation Therapy in Rectal Cancer

  2011cited by this paper
• CD133 expression in rectal cancer after preoperative chemoradiotherapy

  2010cited by this paper
• Abstract 4287: Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment

  2010cited by this paper
• Prognostic value of pretreatment CD44 mRNA in peripheral blood of patients with locally advanced head and neck cancer.

  2010cited by this paper
• Proliferating Cell Nuclear Antigen as a Prognostic Factor After Total Mesorectal Excision of Stage II–III Rectal Cancer

  2009cited by this paper
• Association of reactive oxygen species levels and radioresistance in cancer stem cells

  2009cited by this paper
• Postoperative chemotherapy after neoadjuvant chemoradiation and surgery for rectal cancer: Is it essential for patients with ypT0‐2N0?

  2009cited by this paper
• Tumour-initiating cells: challenges and opportunities for anticancer drug discovery

  2009cited by this paper
• Accuracy of endorectal ultrasonography and computed tomography for restaging rectal cancer after preoperative chemoradiation.

  2008cited by this paper
• Preoperative chemoradiation followed by transanal excision for rectal cancer.

  2008cited by this paper
• Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.

  2007cited by this paper
• Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapy

  2007cited by this paper
• The Potential of Restaging in the Prediction of Pathologic Response After Preoperative Chemoradiotherapy for Rectal Cancer

  2007cited by this paper
• The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation.

  2006cited by this paper
• Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

  2006cited by this paper
• COX-2 overexpression in pretreatment biopsies predicts response of rectal cancers to neoadjuvant radiochemotherapy.

  2006cited by this paper
• Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer.

  2005cited by this paper
• Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.

  2005cited by this paper
• Radiation induced MMP expression from rectal cancer is short lived but contributes to in vitro invasion.

  2005cited by this paper
• Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatment.

  2005cited by this paper
• VEGF as a predictive marker of rectal tumor response to preoperative radiotherapy

  2005cited by this paper
• Bax, a predictive marker for therapeutic response to preoperative chemoradiotherapy in patients with rectal carcinoma.

  2005cited by this paper
• Preoperative versus postoperative chemoradiotherapy for rectal cancer.

  2004cited by this paper
• Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation Therapy: Long-term Results

  2004cited by this paper
• Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region.

  2003cited by this paper
• Preoperatively Irradiated Rectal Carcinoma: Analysis of the Histopathologic Response and Predictive Value of Proliferating Cell Nuclear Antigen Immunostaining

  2003cited by this paper
• Anticancer therapy targeting the apoptotic pathway.

  2003cited by this paper
• Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer.

  2002cited by this paper
• On the practice of dichotomization of quantitative variables.

  2002cited by this paper
• TP53 Genotype but Not p53 Immunohistochemical Result Predicts Response to Preoperative Short-Term Radiotherapy in Rectal Cancer

  2002cited by this paper
• Local Excision of T2 and T3 Rectal Cancers After Downstaging Chemoradiation

  2001cited by this paper
• Molecular prognostic factors in rectal cancer treated by radiation and surgery

  2000cited by this paper
• Tumor volume: a basic and specific response predictor in radiotherapy.

  1998cited by this paper
• Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenes

  1997cited by this paper
• Tumor volume and local control probability: clinical data and radiobiological interpretations.

  1996cited by this paper
• Tumor proliferation in rectal cancer following preoperative irradiation.

  1995cited by this paper

• Can We Predict Which Patients with Rectal Cancer Will Have a Complete Response to Neoadjuvant Therapy?

  2026cites this paper
• Role of CD44 in Chemotherapy Treatment Outcome: A Scoping Review of Clinical Studies

  2024cites this paper
• A multi-class classification algorithm based on hematoxylin-eosin staining for neoadjuvant therapy in rectal cancer: a retrospective study

  2023cites this paper
• Screening of MicroRNA Related to Irradiation Response and the Regulation Mechanism of miRNA-96-5p in Rectal Cancer Cells

  2021cites this paper
• Validation of Gene Expression-Based Predictive Biomarkers for Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

  2021cites this paper
• Nomogram for prediction of pathologic complete remission using biomarker expression and endoscopic finding after preoperative chemoradiotherapy in rectal cancer

  2020cites this paper
• Analysis of influencing factors of no/low response to preoperative concurrent chemoradiotherapy in locally advanced rectal cancer

  2020cites this paper
• Current status of surgical treatment of rectal cancer in China

  2020cites this paper
• Predicting pathological response to chemoradiotherapy for rectal cancer: a systematic review

  2020cites this paper
• Monitoring of Early Changes of Circulating Tumor DNA in the Plasma of Rectal Cancer Patients Receiving Neoadjuvant Concomitant Chemoradiotherapy: Evaluation for Prognosis and Prediction of Therapeutic Response

  2020cites this paper
• Predicting Response to Neoadjuvant Therapy in Colorectal Cancer Patients the Role of Messenger-and Micro-RNA Profiling

  2020cites this paper
• Title: CEA Decline Predicts Tumor Regression and Prognosis in Locally Advanced Rectal Cancer Patients with Elevated Baseline CEA Authors:

  2020cites this paper
• CEA Decline Predicts Tumor Regression and Prognosis in Locally Advanced Rectal Cancer Patients with Elevated Baseline CEA

  2020cites this paper
• Pre-Treatment T2-WI Based Radiomics Features for Prediction of Locally Advanced Rectal Cancer Non-Response to Neoadjuvant Chemoradiotherapy: A Preliminary Study

  2020cites this paper
• Predictive value of serum and tissue carcinoembryonic antigens for radiologic response and oncologic outcome of rectal cancer.

  2020cites this paper
• O6-methylguanine-DNA Methyltransferase Promoter Methylation in Patients with Rectal Adenocarcinoma After Chemoradiotherapy Treatment: Clinical Implications

  2019cites this paper
• A multi-gene model for predicting tumor responsiveness after preoperative chemoradiotherapy for rectal cancer.

  2019cites this paper
• The Prognostic and Clinical Value of CD44 in Colorectal Cancer: A Meta-Analysis

  2019cites this paper
• Are there predictors that can determine neoadjuvant treatment responses in rectal cancer?

  2019cites this paper
• The value of diffusion kurtosis imaging in assessing mismatch repair gene expression of rectal carcinoma: Preliminary findings

  2019cites this paper
• Network Mapping of Molecular Biomarkers Influencing Radiation Response in Rectal Cancer.

  2019influential citation
• Volumetric imaging parameters are significant for predicting the pathological complete response of preoperative concurrent chemoradiotherapy in local advanced rectal cancer

  2019cites this paper
• Predicting the pathological response to neoadjuvant chemoradiation using untargeted metabolomics in locally advanced rectal cancer.

  2018cites this paper
• Clinical and molecular diagnosis of pathologic complete response in rectal cancer: an update

  2018cites this paper
• Neutrophil-Lymphocyte Ratio as a Prognostic Factor in Incurable Stage IV Colorectal Cancer

  2018cites this paper
• Modulation of MGMT and CD 133 Expression in HCT 15 Colon Cancer Cells Exposed To 5-Fluorouracile versus HCT 15 Cancer Stem Cells

  2018cites this paper
• Non-operative management of rectal cancer: understanding tumor biology.

  2018cites this paper
• Current issues of preoperative radio(chemo)therapy and its future evolution in locally advanced rectal cancer.

  2017cites this paper
• The Prognostic Value of Tyrosine Kinase SRC Expression in Locally Advanced Rectal Cancer

  2017cites this paper
• Molecular Biology: Are We Getting Any Closer to Providing Clinically Useful Information?

  2017cites this paper
• Prediction of radio-responsiveness with immune-profiling in patients with rectal cancer

  2017cites this paper
• Predictive clinical model of tumor response after chemoradiation in rectal cancer

  2017cites this paper
• Lessons Learned From the Quest for Gene Signatures That Predict Treatment Response in Rectal Cancer.

  2016cites this paper
• Prognostic significance of survivin in rectal cancer patients treated with surgery and postoperative concurrent chemo-radiation therapy

  2016cites this paper
• Pathologic stage following preoperative chemoradiotherapy underestimates the risk of developing distant metastasis in rectal cancer: A comparison to staging without preoperative chemoradiotherapy

  2016cites this paper
• Mismatch Repair Gene Expression as a Predictor of Tumor Responses in Patients With Rectal Cancer Treated With Preoperative Chemoradiation

  2016cites this paper
• Predictive value of vrk 1 and 2 for rectal adenocarcinoma response to neoadjuvant chemoradiation therapy: a retrospective observational cohort study

  2016cites this paper
• Biomarker-Based Scoring System for Prediction of Tumor Response After Preoperative Chemoradiotherapy in Rectal Cancer by Reverse Transcriptase Polymerase Chain Reaction Analysis

  2016cites this paper
• Prognostic significance of pathological response to preoperative chemoradiotherapy in patients with locally advanced rectal cancer

  2016cites this paper
• Predicting pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review

  2016cites this paper
• Molecular phenotypes of colorectal cancer and potential clinical applications

  2015cites this paper
• Clinical Complete Response After Neoadjuvant Therapy in Rectal Cancer: Is Surgery Needed?

  2015cites this paper
• New Perspectives on Predictive Biomarkers of Tumor Response and Their Clinical Application in Preoperative Chemoradiation Therapy for Rectal Cancer

  2015cites this paper
• Molecular Markers Predictive of Chemotherapy Response in Colorectal Cancer

  2015cites this paper
• Predictive and prognostic biomarkers for neoadjuvant chemoradiotherapy in locally advanced rectal cancer.

  2015influential citation
• Is Pathologic Near-Total Regression an Appropriate Indicator of a Good Response to Preoperative Chemoradiotherapy Based on Oncologic Outcome of Disease?

  2015cites this paper
• Prognostic Effect of Pretreatment Serum Carcinoembryonic Antigen Level

  2015cites this paper
• Factors Associated With Oncologic Outcomes Following Abdominoperineal or Intersphincteric Resection in Patients Treated With Preoperative Chemoradiotherapy

  2015cites this paper
• Impact of Perineural and Lymphovascular Invasion on Oncological Outcomes in Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy and Surgery

  2015cites this paper
• Thymidine phosphorylase and hypoxia-inducible factor 1-α expression in clinical stage II/III rectal cancer: association with response to neoadjuvant chemoradiation therapy and prognosis.

  2015cites this paper
• Can We Predict Response and/or Resistance to Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer?

  2014cites this paper
• Prediction of response to preoperative chemoradiotherapy in patients with locally advanced rectal cancer.

  2014influential citation